Current and historical daily PE Ratio for EirGenix Inc (
) from 2016 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. EirGenix stock (ROCO:6589) PE ratio as of Jun 20 2024 is 0.
More Details
EirGenix Inc (ROCO:6589) PE Ratio (TTM) Chart
EirGenix Inc (ROCO:6589) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1215
- 1
- 2
- 3
- 4
- 5
- 6
- 14
EirGenix PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-20 | At Loss | 2024-04-16 | At Loss |
2024-06-19 | At Loss | 2024-04-15 | At Loss |
2024-06-18 | At Loss | 2024-04-12 | At Loss |
2024-06-17 | At Loss | 2024-04-11 | At Loss |
2024-06-14 | At Loss | 2024-04-10 | At Loss |
2024-06-13 | At Loss | 2024-04-09 | At Loss |
2024-06-12 | At Loss | 2024-04-08 | At Loss |
2024-06-11 | At Loss | 2024-04-03 | At Loss |
2024-06-07 | At Loss | 2024-04-02 | At Loss |
2024-06-06 | At Loss | 2024-04-01 | At Loss |
2024-06-05 | At Loss | 2024-03-29 | At Loss |
2024-06-04 | At Loss | 2024-03-28 | At Loss |
2024-06-03 | At Loss | 2024-03-27 | At Loss |
2024-05-31 | At Loss | 2024-03-26 | At Loss |
2024-05-30 | At Loss | 2024-03-25 | At Loss |
2024-05-29 | At Loss | 2024-03-22 | At Loss |
2024-05-28 | At Loss | 2024-03-21 | At Loss |
2024-05-27 | At Loss | 2024-03-20 | At Loss |
2024-05-24 | At Loss | 2024-03-19 | At Loss |
2024-05-23 | At Loss | 2024-03-18 | At Loss |
2024-05-22 | At Loss | 2024-03-15 | At Loss |
2024-05-21 | At Loss | 2024-03-14 | At Loss |
2024-05-20 | At Loss | 2024-03-13 | At Loss |
2024-05-17 | At Loss | 2024-03-12 | At Loss |
2024-05-16 | At Loss | 2024-03-11 | At Loss |
2024-05-15 | At Loss | 2024-03-08 | At Loss |
2024-05-14 | At Loss | 2024-03-07 | At Loss |
2024-05-13 | At Loss | 2024-03-06 | At Loss |
2024-05-10 | At Loss | 2024-03-05 | At Loss |
2024-05-09 | At Loss | 2024-03-04 | At Loss |
2024-05-08 | At Loss | 2024-03-01 | At Loss |
2024-05-07 | At Loss | 2024-02-29 | At Loss |
2024-05-06 | At Loss | 2024-02-27 | At Loss |
2024-05-03 | At Loss | 2024-02-26 | At Loss |
2024-05-02 | At Loss | 2024-02-23 | At Loss |
2024-04-30 | At Loss | 2024-02-22 | At Loss |
2024-04-29 | At Loss | 2024-02-21 | At Loss |
2024-04-26 | At Loss | 2024-02-20 | At Loss |
2024-04-25 | At Loss | 2024-02-19 | At Loss |
2024-04-24 | At Loss | 2024-02-16 | At Loss |
2024-04-23 | At Loss | 2024-02-15 | At Loss |
2024-04-22 | At Loss | 2024-02-05 | At Loss |
2024-04-19 | At Loss | 2024-02-02 | At Loss |
2024-04-18 | At Loss | 2024-02-01 | At Loss |
2024-04-17 | At Loss | 2024-01-31 | At Loss |
EirGenix Inc (ROCO:6589) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
EirGenix Inc
ISIN : TW0006589005
Description
EirGenix Inc is engaged in biosimilar and new drug research and development as well as biopharmaceutical contract development and manufacturing services, including cell line construction platforms, process development platforms, analytical science and protein characterisation, as well as PIC/S facilities to provide clinical trial drug production. Its services include Cell Line Development, Process Development, Analytical Science and Quality Control, cGMP manufacturing-mammalian system, cGMP manufacturing-microbial system, and Antibody Drug Conjugate.